DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
+10.93%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$355M
AUM Growth
+$355M
(-4.5%)
Cap. Flow
-$38.9M
Cap. Flow
% of AUM
-10.97%
Top 10 Holdings %
Top 10 Hldgs %
50.26%
Holding
91
New
4
Increased
16
Reduced
26
Closed
11
Top Buys
| 1 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$8.48M |
| 2 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$4.38M |
| 3 |
Biohaven
BHVN
|
$3.28M |
| 4 |
BioCryst Pharmaceuticals
BCRX
|
$2.88M |
| 5 |
KalVista Pharmaceuticals
KALV
|
$2.44M |
Top Sells
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$16.6M |
| 2 |
CBAY
Cymabay Therapeutics
CBAY
|
$9.61M |
| 3 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$4.65M |
| 4 |
89bio
ETNB
|
$4.21M |
| 5 |
Adicet Bio
ACET
|
$2.72M |
Sector Composition
| 1 | Healthcare | 81.88% |
